Aspen Pharmacare had discussed destroying its stockpile of life-saving cancer drugs in order to drive up prices by 4000%, according to a report by The Times of London.
This comes after the JSE-listed pharmaceutical company bought the rights to five cancer drugs from GlaxoSmithKline.
The company [Aspen Pharmacare] would have enjoyed a monopoly in the marketplace and was no doubt tempted to use its newly gained power to exploit its customers and reap fabulous returns for its shareholders...— Rob Worthington-Smith, FarSightFirms
FarSightFirms rates the maturity of a company’s leadership based on how it responds to material non-financial issues (material to the medium- to long-term financial sustainability of the company).
It did extensive research into Aspen Pharmacare.
The drug maker also failed to disclose its 2016 €5.2-million Italian competition authority fine for price gouging.
Is Aspen Pharmacare morally bankrupt?
The Money Show’s Bruce Whitfield interviewed Worthington-Smith.
Although Aspen Pharmacare Chairperson Kuseni Dlamini was scheduled to talk to Whitfield he decided not to come on the show when he heard what the topic of conversation was.
Listen to the interview in the audio below (and/or scroll down for quotes from it).
They [Aspen Pharmacare] make fluffy statements about caring for customers…— Rob Worthington-Smith, FarSightFirms
You can’t be cheating the marketplace.— Rob Worthington-Smith, FarSightFirms
There isn’t evidence of a moral code.— Rob Worthington-Smith, FarSightFirms
It’s important that companies stand for something.— Rob Worthington-Smith, FarSightFirms
I’d love to think Aspen Pharmacare has a communication problem [instead of an ethics one].— Rob Worthington-Smith, FarSightFirms
Enter your email address in the form below to receive a newsletter containing the most-read articles of the week from Bruce Whitfield’s The Money Show every Friday morning in your inbox.
The Money Show’s Bruce Whitfield interviews four reps from businesses that are sacrificing some profit for the good of society.
Bruce Whitfield interviews famed CapeTalk presenter John Maytham about his new book "Rapid Fire: Remarkable Miscellany".
The Money Show’s Bruce Whitfield interviews JM Busha Investment Group Managing Director Joseph Busha.
What’s behind the stunning fall of the EOH share price? Bruce Whitfield interviews Traders Corner share trader Garth Mckenzie.
Trofin fund manager Claudius Rostoll on why he believes these three companies are the best investments on the JSE right now.
Aspen Group released results saying the international business delivered 49% of gross revenue.
Wasanga speaks to Co-founder of AquaRenu, Nkosinathi Nkomo about turning a problem into an opportunity.
Ndlozi explains the significance of the the first chapter of his thesis: 'Trauma in the archives'.
The Money Show’s Bruce Whitfield interviews Steinhoff International Chairperson Christo Wiese.
Urologist Dr Shingai Mutambirwa says penile curvature is only a concern if it impedes a man's ability to have penetrative sex.
The EFF lawyer stole the show during the state capture report court battle.
Bruce Whitfield interviews the remarkable Wiese (net worth R100 billion!) about how it all began and where it’s going.
WIN R2000! But only if you can prove you're a whiz of the MTN Biz Quiz by answering the following three questions...
Is social trend Blesserfinder, where girls are allegedly matching up with rich 'benefactors' in exchange for sex, a real thing?